Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,419,568
-
Share change
-
-72,211
-
Total reported value
-
$693,000
-
Price per share
-
$0.49
-
Number of holders
-
12
-
Value change
-
-$52,354
-
Number of buys
-
1
-
Number of sells
-
6
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q1 2020
As of 31 Mar 2020,
IGC Pharma, Inc. - COM NEW (IGC) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,419,568 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Carroll Financial Associates, Inc., DEARBORN PARTNERS LLC, BlackRock Inc., NORTHERN TRUST CORP, GOLDMAN SACHS GROUP INC, BANK OF MONTREAL /CAN/, Sowell Financial Services LLC, and TRUIST FINANCIAL CORP.
This page lists
12
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.